Background illustration for clinical trials search

Paid Clinical Trials Irving

Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age

for
Chickenpox
Location: Dallas TX, Houston TX, Richmond TX, Lafayette LA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 1

Code: NCT06693895

Phase 3, Recruiting

Sickle Cell Kidney Biorepository

for
Sickle Cell Trait, Sickle Cell Disease (SCD),
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 65

Code: NCT07064174

Recruiting

PARTNER 3 Trial - Aortic Valve-in-Valve

for
Aortic Stenosis, Aortic Stenosis, Severe
Location: Dallas TX, Houston TX, New Orleans LA, Saint Louis MO,
Sponsor: Edwards Lifesciences

Sex: All

Age: 0+

Code: NCT03003299

Recruiting

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

for
Influenza
Location: Dallas TX, Plano TX, Edmond OK, Tulsa OK, Houston TX,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 12+

Code: NCT07159763

Phase 3, Recruiting

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

for
Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia
Location: Dallas TX, Laredo TX, Appleton WI, Toledo OH,
Sponsor: NGM Biopharmaceuticals, Inc

Sex: All

Age: 18+

Code: NCT07033026

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

for
Prosthetic-joint Infection
Location: Dallas TX, Shreveport LA, Katy TX, Edinburg TX,
Sponsor: Peptilogics

Sex: All

Age: 18 - 70+

Code: NCT07214311

Phase 2, Phase 3, Recruiting

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Dallas TX, Memphis TN, Kansas City KS, St Louis MO,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07358078

Recruiting

Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion

for
Left Atrial Appendage Closure
Location: Plano TX
Sponsor: Baylor Research Institute

Sex: All

Age: 18 - 70+

Code: NCT06348394

Recruiting

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

for
Advanced Hepatocellular Carcinoma,
Location: Dallas TX, Houston TX, San Antonio TX, Atlanta GA,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06600321

Phase 1, Recruiting

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

for
Obesity, Overweight
Location: Dallas TX, Mesquite TX, Longview TX, Round Rock TX,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07752979

Phase 2, Recruiting

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

for
Breast Cancer, Metastatic
Location: Dallas TX, Houston TX, St Louis MO, Omaha NE, Golden CO,
Sponsor: ALX Oncology Inc.

Sex: All

Age: 18+

Code: NCT07007559

Phase 2, Recruiting

A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

for
Apnea, Sleep Disorders, Overweight and/or Obesity
Location: Dallas TX, Little Rock AR, Cullman AL, Maplewood MN,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07823608

Phase 3, Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

for
Overweight, Obesity
Location: Dallas TX, Plano TX, Mesquite TX, Fort Worth TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07282600

Phase 3, Recruiting

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

for
Type 2 Diabetes, Cortisol Excess
Location: Dallas TX, Lewisville TX, Lampasas TX, Round Rock TX,
Sponsor: Sparrow Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07296484

Phase 2, Recruiting

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Dallas TX, Norman OK, Oklahoma City OK, Tomball TX,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351058

Phase 3, Recruiting

A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near and Intermediate Vision in Pseudophakic Presbyopic Subjects

for
Presbyopia, Pseudophakia
Location: Dallas TX, Houston TX, San Antonio TX, Sioux Falls SD,
Sponsor: ReVision Optics, Inc.

Sex: All

Age: 50+

Code: NCT02668523

Phase 3, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for
Somatostatin Receptor Positive (SSTR+),
Location: Dallas TX, Fayetteville AR, New Orleans LA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase 3, Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

for
Prostate Cancer
Location: Dallas TX, San Antonio TX, Metairie LA, Kansas City KS,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06780670

Phase 2, Phase 3, Recruiting

A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

for
RSV Infection
Location: Weatherford TX, Houston TX, New Orleans LA,
Sponsor: Pfizer

Sex: All

Age: 0+

Code: NCT06866405

Phase 3, Recruiting

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Dallas TX, Toronto, Montreal, Boston MA
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07570979

Phase 1, Recruiting